Colorectal Cancer Study 


Colorectal cancer, also known as bowel cancercolon cancer, or rectal cancer, is any cancer that affects the colon and the rectum. The American Cancer Society estimate that about 1 in 21 men and 1 in 23 women in the United States will develop colorectal cancer during their lifetime.

The Study

  • The main goal of the Study is to collect health information and blood samples from people who are at average risk for colorectal cancer and are scheduled to undergo a routine colonoscopy screening test.

Qualified Participants

  • Males or females 45-84 intending to undergo screening colonoscopy
  • Considered by a physician or healthcare provider as being of ‘average risk’ for CRC
  • Willing to consent to blood draw pre-bowel preparation administration prior to undergoing colonoscopy within 60 days of the date of the investigational blood draw
  • Willing to continue follow ups for up to 2 years 

If Qualified & you Participate you will Receive;

  • Study-related care at no cost
  • Highest standards of care overseen by a licensed Physician
  • Compensation for time and travel
  • Insurance is not required

Fill out the form on the right-hand side of the page and see if you qualify for our clinical trial →

Express Enrollment


Make an appointment and we’ll contact you.